• Drug Discovery
  • Cancer Research UK Funded Institutes
  • Small Molecule Drug Discovery
  • Discovery Committee
• CRT's Discovery Laboratories
  • What we do
  • Our Pipeline
  • Our Senior Scientists
  • Our Scientific Advisory Board
  • Case studies
• Imaging & Diagnostics
• Drug Development
• Partnerships with Industry
  • Academic Consortia
  • Drug Discovery Alliances
  • Cancer Metabolism
  • DNA Damage Response

Drug Discovery Alliances

At CRT, we recognise the need to make breakthroughs in specific areas of promising biology to create innovative new medicines. Through our substantial network of academic scientists and Research Institutes, we are able to pull together research discoveries from several thousand researchers located in more than 50 research centres across the UK and globally. Pharmaceutical companies are becoming less and less enthusiastic about investing in high-risk, early drug discovery themselves, particularly in a single project deal and instead are looking to external organisations to provide multiple promising projects to take forward over a themed area of biology.

Such alliances allow both parties to work to their individual strengths of academic research and drug discovery and pharma clinical development - building deeper expertise, making the combined team more competitive, which increases the likelihood of discoveries being taken to market and increasing the number of potential treatments for cancer patients. The result is a close and transparent way of working with unanimity required for decisions to be taken.